Display options
Cite
Assari S, Wisseh C, Saqib M, et al. Polypharmacy and Depressive Symptoms in U.S.-Born Mexican American Older Adults. Psych. 2019;1(1):491-503doi: 10.3390/psych1010038.
Assari, S., Wisseh, C., Saqib, M., Helmi, H., & Bazargan, M. (2019). Polypharmacy and Depressive Symptoms in U.S.-Born Mexican American Older Adults. Psych, 1(1), 491-503. https://doi.org/10.3390/psych1010038
Assari, Shervin, et al. "Polypharmacy and Depressive Symptoms in U.S.-Born Mexican American Older Adults." Psych vol. 1,1 (2019): 491-503. doi: https://doi.org/10.3390/psych1010038
Assari S, Wisseh C, Saqib M, Helmi H, Bazargan M. Polypharmacy and Depressive Symptoms in U.S.-Born Mexican American Older Adults. Psych. 2019 Dec;1(1):491-503. doi: 10.3390/psych1010038. Epub 2019 Nov 01. PMID: 33205042; PMCID: PMC7668560.
Copy Download .nbib Format: NLM
Share it on

Psych. 2019 Dec;1(1):491-503. doi: 10.3390/psych1010038. Epub 2019 Nov 01.

Polypharmacy and Depressive Symptoms in U.S.-Born Mexican American Older Adults.

Psych

Shervin Assari, Cheryl Wisseh, Mohammed Saqib, Hamid Helmi, Mohsen Bazargan

Affiliations

  1. Department of Family Medicine, Charles R Drew University of Medicine and Science, Los Angeles, CA 90059, USA.
  2. Department of Pharmacy Practice, West Coast University School of Pharmacy, Los Angeles, CA 91606, USA.
  3. Department of Health Behavior and Health Education, University of Michigan, Ann Arbor, MI 48109, USA.
  4. School of Medicine, Wayne State University, Detroit, MI 48202, USA.
  5. Department of Family Medicine, University of California, Los Angeles (UCLA), Los Angeles, CA 90095, USA.

PMID: 33205042 PMCID: PMC7668560 DOI: 10.3390/psych1010038

Abstract

BACKGROUND: Although some studies have suggested a link between polypharmacy and poor mental health, less is known about the association between polypharmacy and depressive symptomology among U.S.-born older Mexican Americans.

AIM: This study aimed to test the association between polypharmacy and depressive symptoms in U.S.-born older Latino Americans.

MATERIALS AND METHODS: Data came from the Sacramento Area Latino Study on Aging (SALSA 2008). A total of 691 U.S.-born older (age >= 65) Mexican Americans entered this analysis. Polypharmacy was the independent variable. Level of depressive symptoms was the outcome. Age, gender, socioeconomic status (education, income, and employment), retirement status, health (chronic medical conditions, self-rated health, and activities of daily living), language, acculturation, and smoking were the covariates. A linear regression model was used to analyze the data.

RESULTS: We found a positive association between polypharmacy and depressive symptoms, which was above and beyond demographic factors, socioeconomic status, physical health, health behaviors, language, acculturation, and health insurance.

CONCLUSION: Polypharmacy is linked to depressive symptoms in U.S.-born older Mexican Americans. More research is needed to test the effects of reducing inappropriate polypharmacy on mental well-being of first and second generation older Mexican Americans. There is also a need to study the role of drug-drug interaction in explaining the observed link between polypharmacy and depressive symptoms.

Keywords: Hispanics; Latino; Mexican Americans; depressive symptoms; ethnic groups; ethnicity; polypharmacy

Conflict of interest statement

Conflicts of Interest The authors declare no conflict of interests.

References

  1. J Racial Ethn Health Disparities. 2017 Jun;4(3):385-396 - PubMed
  2. Braz J Psychiatry. 2017 Oct-Dec;39(4):293-301 - PubMed
  3. Drug Saf. 2008;31(1):7-20 - PubMed
  4. JAMA. 1963 Sep 21;185:914-9 - PubMed
  5. J Tehran Heart Cent. 2015;10(1):24-33 - PubMed
  6. Pharmacy (Basel). 2019 Apr 25;7(2): - PubMed
  7. Hisp Health Care Int. 2010 Mar 1;8(1):14-22 - PubMed
  8. J Diabetes Metab Disord. 2014 Jan 06;13(1):3 - PubMed
  9. Geriatr Nurs. 2015 Sep-Oct;36(5):367-371.e4 - PubMed
  10. Schizophr Res. 2013 Jan;143(1):215-20 - PubMed
  11. Ethiop J Health Sci. 2013 Nov;23(3):283-8 - PubMed
  12. J Affect Disord. 2012 Feb;136(3):212-21 - PubMed
  13. Am J Epidemiol. 2011 May 15;173(10):1148-58 - PubMed
  14. J Am Pharm Assoc (2003). 2017 Nov - Dec;57(6):729-738.e10 - PubMed
  15. Gerontologist. 1969 Autumn;9(3):179-86 - PubMed
  16. Ir Med J. 2010 Sep;103(8):236-8 - PubMed
  17. Int J Environ Res Public Health. 2019 May 06;16(9): - PubMed
  18. BMC Geriatr. 2019 Jan 18;19(1):15 - PubMed
  19. PLoS One. 2018 Sep 18;13(9):e0204018 - PubMed
  20. Acta Psychiatr Scand. 2018 May;137(5):401-412 - PubMed
  21. Am Psychol. 1997 Jan;52(1):25-31 - PubMed
  22. Psychol Assess. 2018 Apr;30(4):459-473 - PubMed
  23. BMJ Open. 2018 Jul 19;8(7):e019042 - PubMed
  24. Pharmacopsychiatry. 2007 Mar;40(2):47-52 - PubMed
  25. PLoS One. 2013;8(3):e57510 - PubMed
  26. Pharmacy (Basel). 2019 Mar 29;7(2): - PubMed
  27. Int J Technol Assess Health Care. 2004 Spring;20(2):115-27 - PubMed
  28. Med J Aust. 2009 Apr 6;190(S7):S54-60 - PubMed
  29. Br J Psychiatry. 2000 Dec;177:486-92 - PubMed
  30. J Gerontol B Psychol Sci Soc Sci. 2011 Jul;66 Suppl 1:i102-10 - PubMed
  31. Int J Prev Med. 2015 Sep 03;6:85 - PubMed
  32. Clin Ther. 2008 Feb;30(2):419-27 - PubMed
  33. J Diabetes Metab Disord. 2014 Feb 21;13(1):36 - PubMed
  34. Hisp Health Care Int. 2015;13(2):77-85 - PubMed
  35. J Women Aging. 2001;13(4):39-51 - PubMed
  36. SAGE Open Med. 2019 Apr 22;7:2050312119845715 - PubMed
  37. J Immigr Minor Health. 2015 Feb;17(1):208-16 - PubMed
  38. J Ren Care. 2018 May 27;: - PubMed
  39. Pharmacy (Basel). 2019 Jan 24;7(1): - PubMed
  40. Int J Environ Res Public Health. 2019 Jun 20;16(12): - PubMed
  41. J Am Geriatr Soc. 2001 Jul;49(7):948-53 - PubMed
  42. Am J Epidemiol. 2011 Aug 15;174(4):423-31 - PubMed
  43. J Aging Health. 2020 Aug-Sep;32(7-8):851-860 - PubMed
  44. Soc Psychiatry Psychiatr Epidemiol. 2015 Nov;50(11):1641-56 - PubMed
  45. Evid Based Ment Health. 2003 Aug;6(3):75 - PubMed

Publication Types

Grant support